This Article Full Text Full Text (PDF) All Versions of this Article: 47/3/415    most recent 01.HYP.0000200714.81990.61v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riddle, E. L. Articles by Insel, P. A. Search for Related Content PubMed PubMed Citation Articles by Riddle, E. L. Articles by Insel, P. A. Related Collections Cell signalling/signal transduction Other hypertension Clinical Studies Genetics of cardiovascular disease Related Article

(Hypertension. 2006;47:415.)
© 2006 American Heart Association, Inc.

Original Articles

Polymorphisms and Haplotypes of the Regulator of G Protein Signaling-2 Gene in Normotensives and Hypertensives

Evan L. Riddle; Brinda K. Rana; Kenton K. Murthy; Fangwen Rao; Eleazar Eskin; Daniel T. O’Connor; Paul A. Insel

From the Departments of Pharmacology (E.L.R., D.T.O., P.A.I.), Medicine (F.R., D.T.O., P.A.I.), Psychiatry (B.K.R., K.K.M.), and Computer Science and Engineering (E.E.), University of California San Diego, La Jolla.

Correspondence to Paul A. Insel, University of California San Diego, Department of Pharmacology, 9500 Gilman Drive, La Jolla, CA 92093. E-mail pinsel{at}ucsd.edu

Regulator of G protein signaling (RGS) proteins stimulate the GTPase activity of G subunits of heterotrimeric G proteins, thereby negatively regulating G protein-coupled receptor signaling. RGS2, which preferentially alters G_q-mediated signaling, may be important for cardiovascular health, because knockout of RGS2 in mice is associated with altered smooth muscle relaxation and hypertension. In this study, we determined genetic variation in the human RGS2 gene by sequencing DNA in normotensive and hypertensive populations of whites (n=128) and blacks (n=122). We identified 14 single nucleotide polymorphisms and 2 two-base insertion/deletions (in/del; 1891 to 1892 TC and 2138 to 2139 AA). Although most of the genetic variants were found at low allelic frequency, in particular in coding regions, the 1891 to 1892 TC and 2138 to 2139 AA intronic in/del were in linkage disequilibrium and were associated with hypertension in blacks (P<0.05). We defined several haplotypes for the RGS2 gene, certain of which showed striking differences between whites and blacks. Additionally, 2 haplotypes had significantly different frequencies between hypertensive and normotensive black groups (P<0.05). We conclude that RGS2 is genetically conserved within coding regions but that the intronic in/del define ethnicity-specific haplotypes. Moreover, certain RGS2 variants that occur at greater frequency in hypertensive blacks may serve as ethnicity-specific genetic variants for this disease.

Key Words: hypertension, genetic • G proteins • signal transduction • blood pressure

Related Article:

Regulator of G-Protein Signaling-2 as a Candidate Gene: The Road to Hypertension or Just Another Roadside Marker?

Ross D. Feldman and Robert Gros
Hypertension 2006 47: 337-338. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				D. A. Blizard, A. Lionikas, D. J. Vandenbergh, T. Vasilopoulos, G. S. Gerhard, J. W. Griffith, L. C. Klein, J. T. Stout, H. A. Mack, J. M. Lakoski, et al. Blood pressure and heart rate QTL in mice of the B6/D2 lineage: sex differences and environmental influences Physiol Genomics, February 2, 2009; 36(3): 158 - 166. [Abstract] [Full Text] [PDF]

				P.-a. B. Shih and D. T. O'Connor Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity Hypertension, June 1, 2008; 51(6): 1456 - 1464. [Full Text] [PDF]

				J. W. Smoller, M. P. Paulus, J. A. Fagerness, S. Purcell, L. H. Yamaki, D. Hirshfeld-Becker, J. Biederman, J. F. Rosenbaum, J. Gelernter, and M. B. Stein Influence of RGS2 on Anxiety-Related Temperament, Personality, and Brain Function Arch Gen Psychiatry, March 1, 2008; 65(3): 298 - 308. [Abstract] [Full Text] [PDF]

				Z. Xie, M. C. Gong, W. Su, J. Turk, and Z. Guo Group VIA Phospholipase A2 (iPLA2beta) Participates in Angiotensin II-induced Transcriptional Up-regulation of Regulator of G-protein Signaling-2 in Vascular Smooth Muscle Cells J. Biol. Chem., August 31, 2007; 282(35): 25278 - 25289. [Abstract] [Full Text] [PDF]

				G. Fejes-Toth and A. Naray-Fejes-Toth Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling? Endocrinology, April 1, 2007; 148(4): 1502 - 1510. [Abstract] [Full Text] [PDF]

				J. Bodenstein, R. K. Sunahara, and R. R. Neubig N-Terminal Residues Control Proteasomal Degradation of RGS2, RGS4, and RGS5 in Human Embryonic Kidney 293 Cells Mol. Pharmacol., April 1, 2007; 71(4): 1040 - 1050. [Abstract] [Full Text] [PDF]

				D. L. Roman, J. N. Talbot, R. A. Roof, R. K. Sunahara, J. R. Traynor, and R. R. Neubig Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay Mol. Pharmacol., January 1, 2007; 71(1): 169 - 175. [Abstract] [Full Text] [PDF]

				R. D. Feldman and R. Gros Regulator of G-Protein Signaling-2 as a Candidate Gene: The Road to Hypertension or Just Another Roadside Marker? Hypertension, March 1, 2006; 47(3): 337 - 338. [Full Text] [PDF]